Crystal structure of the complex of the cyclin D dependent kinase Cdk6 bound to the cell-cycle inhibitor p19INK4d

被引:173
作者
Brotherton, DH
Dhanaraj, V
Wick, S
Brizuela, L
Domaille, PJ
Volyanik, E
Xu, X
Parisini, E
Smith, BO
Archer, SJ
Serrano, M
Brenner, SL
Blundell, TL
Laue, ED
机构
[1] Univ Cambridge, Dept Biochem, Cambridge Ctr Mol Recognit, Cambridge CB2 1GA, England
[2] Mitotix Inc, Cambridge, MA 02139 USA
[3] Dupont Merck Pharmaceut Co, Wilmington, DE 19880 USA
[4] Ctr Nacl Biotecnol, Dept Immunol & Oncol, E-28049 Madrid, Spain
基金
英国惠康基金;
关键词
D O I
10.1038/26164
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The crystal structure of the cyclin D-dependent kinase Cdk6 bound to the p19(INK4d) protein has been determined at 1.9 Angstrom resolution. The results provide the first structural Information for a cyclin D-dependent protein kinase and show how the INK4 family of CDK inhibitors bind. The structure indicates that the conformational changes Induced by p19(INK4d) Inhibit both productive binding of ATP and the cyclin-induced rearrangement of the kinase from an Inactive to an active conformation. The structure also shows how binding of an INK4 inhibitor would prevent binding of p27(Kip1), resulting In Its redistribution to other CDKs. identification of the critical residues involved in the Interaction explains how mutations in Cdk4 and p16(INK4a) result in loss of kinase inhibition and cancer.
引用
收藏
页码:244 / 250
页数:7
相关论文
共 49 条
[31]   Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a [J].
Russo, AA ;
Tong, L ;
Lee, JO ;
Jeffrey, PD ;
Pavletich, NP .
NATURE, 1998, 395 (6699) :237-243
[32]   Structural basis of cyclin-dependent kinase activation by phosphorylation [J].
Russo, AA ;
Jeffrey, PD ;
Pavletich, NP .
NATURE STRUCTURAL BIOLOGY, 1996, 3 (08) :696-700
[33]   Transforming growth factor beta stabilizes p15(INK4B) protein, increases p15(INK4B)-cdk4 complexes, and inhibits cyclin D1 cdk4 association in human mammary epithelial cells [J].
Sandhu, C ;
Garbe, J ;
Bhattacharya, N ;
Daksis, J ;
Pan, CH ;
Yaswen, P ;
Koh, J ;
Slingerland, JM ;
Stampfer, MR .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (05) :2458-2467
[34]   A NEW REGULATORY MOTIF IN CELL-CYCLE CONTROL CAUSING SPECIFIC-INHIBITION OF CYCLIN-D/CDK4 [J].
SERRANO, M ;
HANNON, GJ ;
BEACH, D .
NATURE, 1993, 366 (6456) :704-707
[35]   INHIBITORS OF MAMMALIAN G(1) CYCLIN-DEPENDENT KINASES [J].
SHERR, CJ ;
ROBERTS, JM .
GENES & DEVELOPMENT, 1995, 9 (10) :1149-1163
[36]   Cancer cell cycles [J].
Sherr, CJ .
SCIENCE, 1996, 274 (5293) :1672-1677
[37]  
Soos TJ, 1996, CELL GROWTH DIFFER, V7, P135
[38]   Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France [J].
Soufir, N ;
Avril, MF ;
Chompret, A ;
Demenais, F ;
Bombled, J ;
Spatz, A ;
Stoppa-Lyonnet, D ;
Bénard, J ;
Bressac-de Paillerets, B .
HUMAN MOLECULAR GENETICS, 1998, 7 (02) :209-216
[39]   3 PROTEIN-KINASE STRUCTURES DEFINE A COMMON MOTIF [J].
TAYLOR, SS ;
RADZIOANDZELM, E .
STRUCTURE, 1994, 2 (05) :345-355
[40]  
Tsao H, 1998, CANCER RES, V58, P109